Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity

Volume: 317, Issue: 1, Pages: H39 - H48
Published: Jul 1, 2019
Abstract
Doxorubicin is a chemotherapy medication widely used to treat a variety of cancers. Even though it offers one of the most effective anti-cancer treatments, its clinical use is limited because of its strong cardiotoxicity that can lead to fatal conditions. Here, we show that sestrin 1 and sestrin 2, members of the sestrin family of proteins that are stress-inducible regulators of metabolism, are critical for suppressing doxorubicin cardiotoxicity...
Paper Details
Title
Cardioprotective roles of sestrin 1 and sestrin 2 against doxorubicin cardiotoxicity
Published Date
Jul 1, 2019
Volume
317
Issue
1
Pages
H39 - H48
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.